The prevalence of familial hypercholesterolaemia (FH) is significantly higher in the Afrikaans speaking population (Afrikaners) of South Africa than reported in most other populations. A founder gene effect has been proposed to explain the high FH frequency, implying that the same low density lipoprotein (LDL) receptor gene defect is present in the majority of affected Afrikaners. By using DNA amplification and sequence determination, we have detected a point mutation in DNA from two Afrikaner FH homozygotes. A cytosine to guanine base substitution at nucleotide position 681 of the LDL receptor cDNA results in an amino acid change from aspartic acid to glutamic acid at residue 206 in the cysteine rich ligand binding domain of the LDL receptor. Since three previously mapped transport deficient alleles of the LDL receptor were also traced to cysteine rich repeats of the protein, these results suggest that the mutation is responsible for the receptor defective mutation predominantly found in Afrikaner FH homozygotes. The mutation gives rise to an additional DdeI restriction site in DNA of affected subjects and segregation of the mutation with the disease was confirmed in five large Afrikaner FH families. We predict that 65% ofaffected South African Afrikaners carry this particular base substitution. Amplification of genomic DNA, using the polymerase chain reaction method, and restriction enzyme analysis now permit accurate diagnosis of the mutation in subjects with FH. 
Subjects inheriting two mutant LDL receptor genes (FH homozygotes) have no normal receptors and their cholesterol levels are about four times the normal. Coronary artery atherosclerosis usually manifests before the age of 10 in homozygotes and they frequently suffer heart attacks in childhood. In FH heterozygotes inheriting one mutant gene, only half of the LDL receptors are normal, resulting in reduced clearance of LDL from the circulation. Plasma concentrations of LDL are approximately twice the normal value in these patients and they typically suffer heart attacks in their fourth to seventh decade of life.
The prevalence of heterozygous FH appears to be approximately 1 in 500 among the general population of most countries,' but in the South African Afrikaans speaking population (Afrikaners), however, FH occurs at a five to 10 times higher frequency.2 LDL receptor studies of South African FH homozygotes have shown a predominance of a receptor defective mutation of the 'slow maturation' type3 and this finding correlates with a founder gene effect. 4 A similar mutation appears to be responsible for the disease in the Watanabe heritable hyperlipidaemic (WHHL) rabbit and an FH family and in both gene defects were identified in exon 4 of the LDL receptor gene.5 6 The analysis of LDL receptor gene mutations at the The following oligonucleotide primers were synthesised (Beckman Instruments) for amplification of exon 4 of the LDL receptor gene:
Genomic DNA amplification with the Taq polymerase (Amersham International) was performed according to a modification of the procedure described by Saiki et 4 , together with those in exon 9 and the middle of exon 4,13 14 indicates that the high frequency of FH in South Africa is caused by three founder genes. Amplification of genomic DNA from blood and tissue samples by the PCR method, using synthetic oligonucleotides specific for exons 4 and 9, now permits accurate diagnosis of these mutations by restriction enzyme analysis. It will also be possible to use this method to screen unselected subjects of Afrikaner ancestry to determine the frequencies of these mutations in the population.
